- Home
- / Bioxyne
Bioxyne
Stock Price
$0
2024-10-28
Market Capitalization
$26.6 M
2024-10-28
Revenue
$28.4 M
FY, 2025
Bioxyne Summary
Company Summary
- Overview
- Bioxyne is a life sciences, health, and medical technologies company. It offers tested probiotic containing PCC (Lactobacillus fermentum VRI-003) surviving in the acid environment of the stomach and colonising the intestinal tract. The company also develops functional food and beauty products.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Sydney, AU | view all locations
- Website
- https://bioxyne.com/
- Cybersecurity rating
Table of Contents
Key People
Guy Robertson, Chief Financial Officer, Company Secretary
LocationsView all
1 location detected
Sydney, NSW HQ
Australia
suite 506, level 5/50 Clarence St
Bioxyne Financials
Summary Financials
- Revenue (H1, 2026)
- $31.3M
- Gross profit (H1, 2026)
- $18.4M
- Net income (H1, 2026)
- $7.3M
- Cash (H1, 2026)
- $7.6M
- EBIT (H1, 2026)
- $7.7M
- Enterprise value
- $21.7M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026